Palumbo A,Anderson K. Multiple,Myeloma K. Multiple .2011 .. The New England journal of medicine, 364(11) : 1046-1060.
Robert A Kyle MAG,Thomas E Witzig,Martha Q Lacy E Witzig,Rajkumar S Vincent .2003 .Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clinic Proceeding, 78(1) : 21-33.
SV Rajkumar .2022 .Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. American journal of hematology, 97(8) : 1086-1107.
Palumbo A,Avet-Loiseau H,Oliva S,Lokhorst HM,Goldschmidt H .2015 .. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 33(26) : 2863-2869.
Sadaf Humaira,Mohsin HH,Maqbool HH,Zhao Jianjun .2022 .Multiple myeloma etiology and treatment. Journal of Translational Genetics and Genomics, : 663-83.
Maura F,Bolli N,Angelopoulos N,Dawson KJ,Leongamornlert D .2019 .Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nature communications, 10(1) : 3835.
Nijhof IS,van de Donk N,Zweegman S,Lokhorst HM .2018 .Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update. Drugs, 78(1) : 19-37.
Chen C,Li Y,Miao P,Xu Y,Xie Y .2022 .Tumor immune cell infiltration score based model predicts prognosis in multiple myeloma. Scientific reports, 12(1) : 17082.
Pinto V,Bergantim R,Caires HR,Seca H,Guimaraes JE .2020 .. Multiple Myeloma: Available Therapies and Causes of Drug Resistance. Cancers, 12(2) : 407.
Stratmann S,Vesterlund M,Umer HM,Eshtad S,Skaftason A .2023 .Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. , 37(3) : 550-559.
Weaver CJ,Tariman JD .2017 .Multiple Myeloma Genomics: A Systematic Review. , 33(3) : 237-253.
Sturm G,Finotello F,Petitprez F,Zhang JD,Baumbach J,Bioinformatics J .2019 .Comprehensive evaluation of transcriptome-based celltype quantification methods for immuno-oncology.. , 35(14) : i436-i445.
Ren X,Kuan PF .2020 .RNAAgeCalc: A multi-tissue transcriptional age calculator. PLoS One, 15(8) : e0237006.
Becht E,Giraldo NA,Lacroix L,Buttard B,Elarouci N .2016 .Erratum to: Estimating the population abundance of tissueinfiltrating immune and stromal cell populations using gene expression. Genome biology, 17(1) : 249.
Love MI,Huber W .2014 .Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome biology, 15(12) : 550.
Kevin Blighe SR,Myles Lewis SR .2018 .EnhancedVolcano: Publication-ready volcano plots with enhanced colouring and labeling. , : .
Garcia-Moreno A,Lopez-Dominguez R,Villatoro-Garcia JA,Ramirez-Mena A,Aparicio-Puerta E .2022 .. Functional Enrichment Analysis of Regulatory Elements. Biomedicines, 10(3) : .
Wang J,Hu Y,Hamidi H,Dos Santos C,Zhang J .2022 .Immune microenvironment characteristics in multiple myeloma progression from transcriptome profiling. Front Oncol, : 12948548.
Xu L,Yu W,Xiao H,Lin K. .2021 .BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration. Scientific reports, 11(1) : 390.
Hong TM,Chen YL,Wu YY,Yuan A,Chao YC .2007 .Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. , 13(16) : 4759-4768.
.2016 .Stromal VCAN expression as a potential prognostic biomarker for disease recurrence in stage II-III colon cancer. Carcinogenesis, 37(9) : 878-887.
Wang Y,Li W,Jin X,Jiang X,Guo S .2021 .Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. BMC Cancer, 21(1) : 905.
.2014 .Prognostic value of type XXII and XXIV collagen mRNA expression in head and neck cancer patients. Molecular and clinical oncology, 2(2) : 285-291.
Deng M,Aberle MR,van Bijnen A,van der Kroft G,Lenaerts K .2023 .Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia. , 14 : 1159411.
Rosales C. .2018 .Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? Frontiers in physiology. , 9 : 113.
Parrinello N,Romano A,Conticello C,Cavalli M,La Fauci A .2013 .. Neutrophils Of Multiple Myeloma Are Dysfunctional and Immunosuppressive. Blood, 122(21) : 3138-3138.
Romano A,Parrinello NL,Simeon V,Puglisi F,La Cava P .1983 .High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling. Scientific reports, 10(1) : .
Maimela NR,Liu S .2019 .Fates of CD8+ T cells in Tumor Microenvironment. Computational and structural biotechnology journal. , 17 : 1-13.
Cox AD,Der CJ .2010 .Ras history: The saga continues. Small GTPases, 1(1) : 2-27.
Corre J,Cleynen A,Robiou du Pont S,Buisson L,Bolli N .2018 .Multiple myeloma clonal evolution in homogeneously treated patients. Leukemia, 32(12) : 2636-2647.
Hu Y,Chen W,Wang J .2019 .Progress in the identification of gene mutations involved in multiple myeloma. OncoTargets and therapy, 12 : 4075-4080.
Blood .2021 .. , 138(18) : 1705-1720.
Drug discovery .2014 .. , 13(11) : 828-851.
Hobbs GA,Baker NM,Miermont AM,Thurman RD,Pierobon M .2020 .Atypical KRAS(G12R) Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer. Cancer Discovery, 10(1) : 104-123.
Ragusa D,Tosi S,Sisu C .2022 .Pan-Cancer Analysis Identifies MNX1 and Associated Antisense Transcripts as Biomarkers for Cancer. Cells, 11(22) : 3577.
Nilsson T,Waraky A,Ostlund A,Li S,Staffas A .2022 .An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages. International journal of cancer, 151(5) : 770-782.
Yang X,Pan Q,Lu Y,Jiang X,Zhang S .2019 .MNX1 promotes cell proliferation and activates Wnt/beta-catenin signaling in colorectal cancer. Cell biology international,, 43(4) : 402-408.
de Bock CE,Ardjmand A,Molloy TJ,Bone SM,Johnstone D .2012 .The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia, 26(5) : 918-926.
Chen ZG,Saba NF,Teng Y. .2022 .The diverse functions of FAT1 in cancer progression: good, bad, or ugly. Journal of Experimental and Clinical Cancer Research, 41(1) : 248.
Liebig S,Neumann M,Silva P,Ortiz-Tanchez J,Schulze V .2023 .FAT1 expression in T-cell acute lymphoblastic leukemia (T-ALL) modulates proliferation and WNT signaling. Scientific reports, 13(1) : 972.
Adamo P,Ladomery MR .2016 .The oncogene ERG: a key factor in prostate cancer. Oncogene, 35(4) : 403-414.
Khosh Kish E,Choudhry M,Gamallat Y,Buharideen SM,D D SM .2022 .The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer. International journal of molecular sciences,, 23(9) : 4772.
Zhou W,Su Y,Zhang Y,Han B,Liu H .2020 .Activating Akt/mTOR Signaling Pathway. , 10 : 584505.
Paduano F,Gaudio E,Mensah AA,Pinton S,Bertoni F .2018 .: An Oncogene Regulating Multiple Signaling Pathways. T-Cell Leukemia/Lymphoma, 8(TCL1) : 317.
Stachelscheid J,Jiang Q,Aszyk C,Warner K,Bley N .2023 .The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL. Blood, (. , 141(12) : 1425-1441.
Li H,Yan X,Liu L,Huang L,Yin M .2017 .T-cell leukemia/lymphoma-1A predicts the clinical outcome for patients with stage II/III colorectal cancer. Biomed Pharmacother, 88 : 924-930.
Shi Y,Zhao Y,Zhang Y,AiErken N,Shao N .2018 .AFF3 upregulation mediates tamoxifen resistance in breast cancers. Journal of experimental & clinical cancer research, 37(1) : 254.
xi chen QY,Xiang Qin,Long Sili .2021 .High expression of AFFs is related to prognosis of acute myeloid leukemia. PREPRINT (Version, 1 : .
Zeng Y,Zhang X,Li F,Wang Y,Wei M. .2022 .AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. Journal of Clinical Laboratory Analysis, 36(6) : e24437.
Lefevre L,Omeiri H,Drougat L,Hantel C,Giraud M .2015 .; 4(7): e161.. Oncogenesis, : .
Li C,Vides A,Kim D,Xue JY,Zhao Y .2021 .The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS. , 374(6564) : 197-201.
Shi YY,Meng XT,Xu YN,Tian XJ .2021 .Role of FOXO protein's abnormal activation through PI3K/AKT pathway in platinum resistance of ovarian cancer. The journal of obstetrics and gynaecology research, 47(6) : 1946-1957.
Ramakrishnan V,Kumar S. .2018 .PI3K/AKT/mTOR pathway in multiple myeloma: from basic biology to clinical promise. Leuk Lymphoma, 59(11) : 2524-2534.
Wang L,Lin N,Li Y. .2019 .The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma. Oncology Reports, 41(3) : 1678-1690.
van Andel H,Kocemba KA,Spaargaren M,Pals ST .2019 .Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options. Leukemia, 33(5) : 1063-1075.